Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosurgery | 18 | 2024 | 682 | 3.450 |
Why?
|
Brain Neoplasms | 46 | 2024 | 9065 | 2.800 |
Why?
|
Craniotomy | 11 | 2023 | 737 | 1.400 |
Why?
|
Glioblastoma | 20 | 2024 | 3458 | 1.290 |
Why?
|
Neurosurgical Procedures | 24 | 2024 | 2077 | 1.190 |
Why?
|
Glioma | 14 | 2024 | 3491 | 1.100 |
Why?
|
Internship and Residency | 7 | 2024 | 5945 | 1.040 |
Why?
|
Neuronavigation | 1 | 2024 | 170 | 0.830 |
Why?
|
Central Nervous System Neoplasms | 4 | 2024 | 918 | 0.760 |
Why?
|
Spinal Cord Neoplasms | 3 | 2019 | 258 | 0.730 |
Why?
|
Intracranial Aneurysm | 10 | 2012 | 1271 | 0.690 |
Why?
|
School Admission Criteria | 1 | 2020 | 106 | 0.660 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2021 | 240 | 0.660 |
Why?
|
Tremor | 1 | 2020 | 197 | 0.660 |
Why?
|
Telemetry | 1 | 2020 | 201 | 0.650 |
Why?
|
Hydrocephalus | 7 | 2022 | 766 | 0.640 |
Why?
|
Defensive Medicine | 3 | 2015 | 47 | 0.640 |
Why?
|
Astrocytoma | 3 | 2018 | 772 | 0.520 |
Why?
|
Hematoma, Subdural | 2 | 2014 | 128 | 0.520 |
Why?
|
Isocitrate Dehydrogenase | 6 | 2024 | 954 | 0.500 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2016 | 614 | 0.490 |
Why?
|
Dura Mater | 2 | 2015 | 295 | 0.480 |
Why?
|
Thalamus | 1 | 2021 | 1048 | 0.470 |
Why?
|
Intracranial Hemorrhages | 4 | 2014 | 809 | 0.450 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.450 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2013 | 16 | 0.440 |
Why?
|
Motor Cortex | 1 | 2021 | 1003 | 0.430 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2016 | 388 | 0.420 |
Why?
|
Valproic Acid | 1 | 2016 | 444 | 0.420 |
Why?
|
Dacarbazine | 1 | 2016 | 552 | 0.420 |
Why?
|
Interviews as Topic | 1 | 2020 | 2740 | 0.420 |
Why?
|
Conflict of Interest | 3 | 2012 | 556 | 0.410 |
Why?
|
Practice Guidelines as Topic | 6 | 2021 | 7423 | 0.400 |
Why?
|
Cerebellar Neoplasms | 2 | 2014 | 571 | 0.400 |
Why?
|
Drug Monitoring | 1 | 2018 | 960 | 0.390 |
Why?
|
Frontal Sinus | 1 | 2012 | 51 | 0.390 |
Why?
|
Vascular Neoplasms | 1 | 2013 | 167 | 0.390 |
Why?
|
Humans | 157 | 2024 | 765926 | 0.390 |
Why?
|
Tachycardia, Ventricular | 1 | 2020 | 1313 | 0.380 |
Why?
|
Insurance, Liability | 1 | 2012 | 100 | 0.380 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9373 | 0.380 |
Why?
|
Spina Bifida Occulta | 1 | 2011 | 31 | 0.370 |
Why?
|
Hospitals, Special | 1 | 2011 | 88 | 0.360 |
Why?
|
Patents as Topic | 1 | 2012 | 111 | 0.360 |
Why?
|
Skull Fractures | 1 | 2012 | 202 | 0.360 |
Why?
|
Hyperplasia | 1 | 2013 | 1142 | 0.350 |
Why?
|
Fistula | 1 | 2012 | 212 | 0.350 |
Why?
|
Meningeal Carcinomatosis | 2 | 2021 | 65 | 0.350 |
Why?
|
Cervical Vertebrae | 5 | 2016 | 978 | 0.330 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2011 | 109 | 0.330 |
Why?
|
Subarachnoid Hemorrhage, Traumatic | 1 | 2009 | 13 | 0.320 |
Why?
|
Malpractice | 3 | 2015 | 561 | 0.320 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 305 | 0.320 |
Why?
|
Decompressive Craniectomy | 4 | 2015 | 76 | 0.320 |
Why?
|
Spondylitis, Ankylosing | 1 | 2010 | 157 | 0.310 |
Why?
|
Ownership | 1 | 2011 | 338 | 0.310 |
Why?
|
Postoperative Complications | 7 | 2020 | 15802 | 0.300 |
Why?
|
Electrocardiography | 2 | 2020 | 6409 | 0.290 |
Why?
|
Choroid Plexus | 2 | 2007 | 249 | 0.280 |
Why?
|
Telomerase | 4 | 2024 | 749 | 0.280 |
Why?
|
Genetic Linkage | 3 | 2007 | 2342 | 0.270 |
Why?
|
Vasospasm, Intracranial | 1 | 2009 | 207 | 0.270 |
Why?
|
Health Care Surveys | 2 | 2022 | 2426 | 0.270 |
Why?
|
Parkinson Disease | 1 | 2020 | 2885 | 0.270 |
Why?
|
Disease Management | 6 | 2021 | 2530 | 0.260 |
Why?
|
Male | 73 | 2024 | 363815 | 0.260 |
Why?
|
Female | 79 | 2024 | 396141 | 0.260 |
Why?
|
Evidence-Based Practice | 2 | 2020 | 499 | 0.250 |
Why?
|
Adult | 59 | 2024 | 223088 | 0.250 |
Why?
|
Brain Mapping | 6 | 2024 | 6598 | 0.250 |
Why?
|
Central Nervous System Vascular Malformations | 3 | 2011 | 141 | 0.250 |
Why?
|
Airway Obstruction | 1 | 2010 | 672 | 0.240 |
Why?
|
Lymphoma | 2 | 2024 | 1896 | 0.240 |
Why?
|
Oligodendroglioma | 2 | 2016 | 274 | 0.240 |
Why?
|
Radiosurgery | 4 | 2020 | 1328 | 0.240 |
Why?
|
Brain Injuries | 6 | 2015 | 2061 | 0.220 |
Why?
|
Middle Aged | 47 | 2024 | 223016 | 0.220 |
Why?
|
Physicians | 2 | 2012 | 4591 | 0.220 |
Why?
|
Spinal Fractures | 1 | 2010 | 702 | 0.210 |
Why?
|
Microelectrodes | 2 | 2021 | 305 | 0.210 |
Why?
|
Registries | 2 | 2019 | 8346 | 0.210 |
Why?
|
Brain Edema | 3 | 2013 | 601 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3109 | 0.210 |
Why?
|
Bioethics | 1 | 2024 | 118 | 0.210 |
Why?
|
Ventriculostomy | 2 | 2015 | 132 | 0.210 |
Why?
|
Monitoring, Intraoperative | 2 | 2024 | 944 | 0.210 |
Why?
|
Databases, Factual | 3 | 2021 | 8060 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3231 | 0.200 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2004 | 640 | 0.200 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3928 | 0.200 |
Why?
|
Cysts | 1 | 2007 | 684 | 0.200 |
Why?
|
Indocyanine Green | 1 | 2023 | 234 | 0.190 |
Why?
|
Spine | 4 | 2012 | 1132 | 0.190 |
Why?
|
Fourth Ventricle | 2 | 2012 | 32 | 0.190 |
Why?
|
Aged | 35 | 2024 | 171163 | 0.180 |
Why?
|
Gliosarcoma | 1 | 2021 | 115 | 0.180 |
Why?
|
Air Ambulances | 2 | 2012 | 93 | 0.180 |
Why?
|
Meningomyelocele | 1 | 2022 | 182 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8721 | 0.180 |
Why?
|
Telecommunications | 1 | 2020 | 79 | 0.170 |
Why?
|
Vertebral Artery | 2 | 2011 | 185 | 0.170 |
Why?
|
Aneurysm, Ruptured | 1 | 2005 | 455 | 0.170 |
Why?
|
United States | 13 | 2024 | 72909 | 0.170 |
Why?
|
Immunotherapy, Adoptive | 3 | 2024 | 1504 | 0.170 |
Why?
|
Spinal Neoplasms | 2 | 2020 | 708 | 0.170 |
Why?
|
Eccrine Glands | 1 | 2020 | 52 | 0.170 |
Why?
|
Mutation | 11 | 2024 | 30192 | 0.170 |
Why?
|
Congresses as Topic | 3 | 2019 | 811 | 0.170 |
Why?
|
Neurotoxicity Syndromes | 1 | 2023 | 302 | 0.170 |
Why?
|
Single-Cell Analysis | 5 | 2019 | 2536 | 0.160 |
Why?
|
Meningeal Neoplasms | 2 | 2021 | 1252 | 0.160 |
Why?
|
Cerebral Ventricles | 2 | 2015 | 550 | 0.160 |
Why?
|
Neoplastic Stem Cells | 3 | 2017 | 1351 | 0.160 |
Why?
|
Evidence-Based Medicine | 4 | 2021 | 3690 | 0.160 |
Why?
|
Cerebral Ventricle Neoplasms | 2 | 2011 | 43 | 0.160 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.160 |
Why?
|
Intraoperative Complications | 2 | 2019 | 1169 | 0.160 |
Why?
|
Catheterization | 2 | 2016 | 1426 | 0.150 |
Why?
|
Treatment Outcome | 20 | 2020 | 65194 | 0.150 |
Why?
|
Microsurgery | 4 | 2011 | 798 | 0.150 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 109 | 0.150 |
Why?
|
False Positive Reactions | 1 | 2020 | 956 | 0.150 |
Why?
|
Retrospective Studies | 22 | 2024 | 81537 | 0.150 |
Why?
|
Curriculum | 2 | 2023 | 3784 | 0.150 |
Why?
|
Video Recording | 1 | 2023 | 977 | 0.140 |
Why?
|
Stroke | 6 | 2015 | 9739 | 0.140 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2011 | 360 | 0.140 |
Why?
|
Drug Therapy | 1 | 2020 | 504 | 0.140 |
Why?
|
Propofol | 1 | 2023 | 606 | 0.140 |
Why?
|
Bone Marrow | 2 | 2018 | 2916 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 19 | 2024 | 36547 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 260 | 0.140 |
Why?
|
Craniocerebral Trauma | 2 | 2011 | 493 | 0.140 |
Why?
|
Drugs, Investigational | 1 | 2019 | 211 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26282 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11858 | 0.130 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 203 | 0.130 |
Why?
|
Warfarin | 2 | 2016 | 1494 | 0.130 |
Why?
|
Cranial Irradiation | 1 | 2019 | 384 | 0.130 |
Why?
|
Ultrasonography, Interventional | 1 | 2024 | 1519 | 0.130 |
Why?
|
Neuroendoscopes | 1 | 2015 | 7 | 0.130 |
Why?
|
Antigens, Neoplasm | 2 | 2024 | 1995 | 0.130 |
Why?
|
Chondroma | 1 | 2015 | 53 | 0.120 |
Why?
|
Lumbar Vertebrae | 4 | 2016 | 1878 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8522 | 0.120 |
Why?
|
Plasma | 2 | 2016 | 583 | 0.120 |
Why?
|
Acrocephalosyndactylia | 1 | 2016 | 93 | 0.120 |
Why?
|
Critical Pathways | 1 | 2019 | 475 | 0.120 |
Why?
|
Blood Component Transfusion | 1 | 2016 | 141 | 0.120 |
Why?
|
Optic Nerve Neoplasms | 1 | 2015 | 45 | 0.120 |
Why?
|
Young Adult | 16 | 2024 | 59857 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2016 | 193 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 63 | 0.120 |
Why?
|
Aged, 80 and over | 11 | 2024 | 59496 | 0.110 |
Why?
|
Temporal Lobe | 3 | 2018 | 1715 | 0.110 |
Why?
|
Osteophyte | 1 | 2014 | 44 | 0.110 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 2036 | 0.110 |
Why?
|
Glutarates | 1 | 2016 | 243 | 0.110 |
Why?
|
Neuroendoscopy | 1 | 2015 | 100 | 0.110 |
Why?
|
Multicenter Studies as Topic | 3 | 2024 | 1729 | 0.110 |
Why?
|
Leukocytosis | 1 | 2015 | 249 | 0.110 |
Why?
|
Seizures | 3 | 2019 | 2997 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1374 | 0.110 |
Why?
|
Temporal Bone | 2 | 2016 | 683 | 0.110 |
Why?
|
Prospective Studies | 9 | 2024 | 54807 | 0.110 |
Why?
|
Antidotes | 1 | 2014 | 138 | 0.110 |
Why?
|
Scalp | 2 | 2020 | 389 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12973 | 0.110 |
Why?
|
Speech | 1 | 2018 | 556 | 0.110 |
Why?
|
Spinal Cord Compression | 2 | 2014 | 234 | 0.100 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 303 | 0.100 |
Why?
|
Hypernatremia | 1 | 2013 | 78 | 0.100 |
Why?
|
Saline Solution, Hypertonic | 1 | 2013 | 116 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2021 | 5300 | 0.100 |
Why?
|
Arnold-Chiari Malformation | 2 | 2011 | 159 | 0.100 |
Why?
|
Craniopharyngioma | 1 | 2015 | 276 | 0.100 |
Why?
|
Spinal Cord | 2 | 2011 | 1786 | 0.100 |
Why?
|
Brain Concussion | 2 | 2021 | 1432 | 0.100 |
Why?
|
beta-Alanine | 1 | 2013 | 83 | 0.100 |
Why?
|
Microfluidics | 1 | 2018 | 651 | 0.100 |
Why?
|
Developing Countries | 2 | 2024 | 2913 | 0.100 |
Why?
|
Quality of Life | 2 | 2024 | 13463 | 0.100 |
Why?
|
Demyelinating Diseases | 1 | 2015 | 355 | 0.100 |
Why?
|
Guanine Nucleotides | 1 | 2012 | 54 | 0.100 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2013 | 133 | 0.100 |
Why?
|
Fever | 2 | 2021 | 1607 | 0.100 |
Why?
|
Skull Fracture, Basilar | 1 | 2011 | 6 | 0.100 |
Why?
|
Acute Lung Injury | 1 | 2016 | 377 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5691 | 0.100 |
Why?
|
Brain | 9 | 2023 | 27179 | 0.100 |
Why?
|
Spinal Fusion | 2 | 2011 | 1307 | 0.100 |
Why?
|
Blood Coagulation Factors | 1 | 2014 | 372 | 0.100 |
Why?
|
Ambulances | 1 | 2012 | 94 | 0.100 |
Why?
|
Neurocytoma | 1 | 2011 | 28 | 0.100 |
Why?
|
Internet | 2 | 2016 | 3106 | 0.100 |
Why?
|
Sodium-Potassium-Chloride Symporters | 2 | 2009 | 106 | 0.100 |
Why?
|
MELAS Syndrome | 1 | 2012 | 54 | 0.100 |
Why?
|
Cochlear Implantation | 1 | 2016 | 317 | 0.100 |
Why?
|
Hospital-Physician Relations | 1 | 2011 | 17 | 0.090 |
Why?
|
Petrous Bone | 1 | 2011 | 85 | 0.090 |
Why?
|
Abducens Nerve Diseases | 1 | 2012 | 44 | 0.090 |
Why?
|
Hernia | 1 | 2011 | 67 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2017 | 949 | 0.090 |
Why?
|
Rhombencephalon | 1 | 2011 | 81 | 0.090 |
Why?
|
Ion Transport | 2 | 2009 | 322 | 0.090 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2011 | 87 | 0.090 |
Why?
|
Cerebral Cortex | 3 | 2021 | 5765 | 0.090 |
Why?
|
Intracranial Arterial Diseases | 1 | 2011 | 22 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2419 | 0.090 |
Why?
|
Chondroblastoma | 1 | 2011 | 47 | 0.090 |
Why?
|
Syringomyelia | 1 | 2011 | 66 | 0.090 |
Why?
|
Hemifacial Spasm | 1 | 2011 | 23 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 3940 | 0.090 |
Why?
|
Ethics, Research | 1 | 2012 | 178 | 0.090 |
Why?
|
Survival Rate | 4 | 2024 | 12822 | 0.090 |
Why?
|
T-Lymphocytes | 4 | 2024 | 10256 | 0.090 |
Why?
|
Head Injuries, Closed | 1 | 2012 | 133 | 0.090 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2011 | 135 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2021 | 1244 | 0.090 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2011 | 70 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2046 | 0.090 |
Why?
|
Polyradiculopathy | 1 | 2010 | 23 | 0.090 |
Why?
|
Globus Pallidus | 1 | 2012 | 247 | 0.090 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 382 | 0.090 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2012 | 186 | 0.090 |
Why?
|
Transportation of Patients | 1 | 2011 | 177 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 614 | 0.090 |
Why?
|
Income | 1 | 2019 | 1874 | 0.090 |
Why?
|
Stents | 2 | 2013 | 3191 | 0.090 |
Why?
|
Antithrombins | 1 | 2013 | 295 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2053 | 0.090 |
Why?
|
Bone Nails | 1 | 2011 | 221 | 0.090 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2010 | 32 | 0.090 |
Why?
|
Electric Stimulation | 3 | 2021 | 1738 | 0.090 |
Why?
|
Spinal Diseases | 2 | 2014 | 561 | 0.090 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2010 | 37 | 0.080 |
Why?
|
Search Engine | 1 | 2011 | 142 | 0.080 |
Why?
|
Prednisolone | 1 | 2011 | 323 | 0.080 |
Why?
|
Blast Crisis | 1 | 2010 | 102 | 0.080 |
Why?
|
Pituitary Diseases | 1 | 2011 | 137 | 0.080 |
Why?
|
Incidence | 3 | 2019 | 21513 | 0.080 |
Why?
|
Neurocysticercosis | 1 | 2011 | 91 | 0.080 |
Why?
|
Polyvinyls | 1 | 2010 | 153 | 0.080 |
Why?
|
Brain Diseases | 1 | 2019 | 1552 | 0.080 |
Why?
|
Foreign-Body Migration | 1 | 2011 | 219 | 0.080 |
Why?
|
Blood Coagulation | 1 | 2016 | 1171 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 11 | 2019 | 20690 | 0.080 |
Why?
|
Laser Therapy | 1 | 2016 | 1108 | 0.080 |
Why?
|
Cri-du-Chat Syndrome | 1 | 2009 | 13 | 0.080 |
Why?
|
Dimethyl Sulfoxide | 1 | 2010 | 250 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2012 | 379 | 0.080 |
Why?
|
Spondylolisthesis | 1 | 2011 | 173 | 0.080 |
Why?
|
Orthotic Devices | 1 | 2010 | 131 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3592 | 0.080 |
Why?
|
Research Report | 1 | 2012 | 367 | 0.080 |
Why?
|
Neuroma, Acoustic | 1 | 2013 | 456 | 0.080 |
Why?
|
Bone Neoplasms | 2 | 2012 | 2559 | 0.080 |
Why?
|
Epilepsy | 2 | 2021 | 3317 | 0.080 |
Why?
|
Aneurysm, False | 1 | 2011 | 264 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8603 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6274 | 0.080 |
Why?
|
Skull Base | 1 | 2011 | 293 | 0.080 |
Why?
|
Chordoma | 1 | 2012 | 343 | 0.080 |
Why?
|
Language | 1 | 2018 | 1550 | 0.080 |
Why?
|
Surgical Wound Infection | 2 | 2015 | 1544 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2015 | 1408 | 0.080 |
Why?
|
Carcinoma | 1 | 2020 | 2311 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21069 | 0.080 |
Why?
|
Thrombectomy | 1 | 2013 | 676 | 0.080 |
Why?
|
Infant | 8 | 2022 | 36426 | 0.080 |
Why?
|
Facial Nerve | 1 | 2011 | 277 | 0.080 |
Why?
|
Sacrum | 1 | 2010 | 270 | 0.080 |
Why?
|
Brain Stem Neoplasms | 1 | 2010 | 192 | 0.080 |
Why?
|
Vascular System Injuries | 1 | 2011 | 245 | 0.080 |
Why?
|
Hyponatremia | 1 | 2011 | 278 | 0.070 |
Why?
|
Cerebral Revascularization | 1 | 2011 | 260 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 3 | 2016 | 4037 | 0.070 |
Why?
|
Connective Tissue Diseases | 1 | 2011 | 284 | 0.070 |
Why?
|
Nausea | 2 | 2021 | 678 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2013 | 862 | 0.070 |
Why?
|
Famous Persons | 1 | 2009 | 108 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39228 | 0.070 |
Why?
|
Cerebral Aqueduct | 1 | 2007 | 39 | 0.070 |
Why?
|
Lod Score | 2 | 2006 | 599 | 0.070 |
Why?
|
Hospitals | 4 | 2019 | 3886 | 0.070 |
Why?
|
Magnetic Resonance Angiography | 2 | 2011 | 1429 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 452 | 0.070 |
Why?
|
Dystonic Disorders | 1 | 2012 | 354 | 0.070 |
Why?
|
Students, Medical | 1 | 2020 | 1962 | 0.070 |
Why?
|
Clinical Competence | 1 | 2023 | 4855 | 0.070 |
Why?
|
Peripheral Nerves | 1 | 2011 | 491 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1322 | 0.070 |
Why?
|
Aneurysm | 1 | 2010 | 343 | 0.070 |
Why?
|
Steroids | 1 | 2012 | 934 | 0.070 |
Why?
|
Cohort Studies | 8 | 2021 | 41680 | 0.070 |
Why?
|
Cerebral Infarction | 1 | 2011 | 968 | 0.070 |
Why?
|
Prognosis | 5 | 2024 | 29890 | 0.070 |
Why?
|
Hypertension | 2 | 2011 | 8616 | 0.070 |
Why?
|
Hemorrhage | 2 | 2016 | 3466 | 0.070 |
Why?
|
Family Health | 1 | 2011 | 1253 | 0.070 |
Why?
|
Lateral Ventricles | 1 | 2007 | 142 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2007 | 18074 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4882 | 0.070 |
Why?
|
Rare Diseases | 1 | 2012 | 629 | 0.070 |
Why?
|
Bone Transplantation | 1 | 2011 | 920 | 0.070 |
Why?
|
Meningioma | 1 | 2015 | 1221 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2170 | 0.060 |
Why?
|
Postoperative Care | 1 | 2012 | 1475 | 0.060 |
Why?
|
Nervous System Diseases | 2 | 2024 | 1657 | 0.060 |
Why?
|
Critical Care | 2 | 2023 | 2713 | 0.060 |
Why?
|
Anticonvulsants | 1 | 2016 | 1919 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 17060 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6306 | 0.060 |
Why?
|
Decompression, Surgical | 1 | 2011 | 602 | 0.060 |
Why?
|
Cocaine-Related Disorders | 1 | 2009 | 458 | 0.060 |
Why?
|
Chlorides | 1 | 2008 | 666 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2924 | 0.060 |
Why?
|
Endoscopy | 1 | 2015 | 1854 | 0.060 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2006 | 285 | 0.060 |
Why?
|
Disclosure | 1 | 2011 | 756 | 0.060 |
Why?
|
Melanoma | 2 | 2022 | 5695 | 0.060 |
Why?
|
Brain Stem | 1 | 2010 | 854 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2023 | 3799 | 0.060 |
Why?
|
Promoter Regions, Genetic | 3 | 2024 | 5784 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1512 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2006 | 412 | 0.060 |
Why?
|
Third Ventricle | 1 | 2005 | 78 | 0.060 |
Why?
|
Multivariate Analysis | 4 | 2016 | 12059 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4746 | 0.060 |
Why?
|
Patient Transfer | 1 | 2011 | 789 | 0.060 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2005 | 197 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13631 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2823 | 0.060 |
Why?
|
Embolization, Therapeutic | 2 | 2010 | 1405 | 0.060 |
Why?
|
Emergency Medical Services | 2 | 2012 | 1937 | 0.050 |
Why?
|
Heparin | 1 | 2011 | 1632 | 0.050 |
Why?
|
Social Class | 1 | 2012 | 2007 | 0.050 |
Why?
|
Mentors | 1 | 2009 | 671 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13614 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4904 | 0.050 |
Why?
|
International Normalized Ratio | 2 | 2016 | 382 | 0.050 |
Why?
|
Medicaid | 1 | 2016 | 2833 | 0.050 |
Why?
|
Bioethical Issues | 1 | 2024 | 119 | 0.050 |
Why?
|
Deep Brain Stimulation | 1 | 2012 | 849 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3318 | 0.050 |
Why?
|
Anticoagulants | 2 | 2016 | 4856 | 0.050 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 179 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2011 | 1506 | 0.050 |
Why?
|
Penetrance | 1 | 2004 | 388 | 0.050 |
Why?
|
Adolescent | 9 | 2019 | 88811 | 0.050 |
Why?
|
Molecular Biology | 1 | 2006 | 573 | 0.050 |
Why?
|
Estrogen Receptor beta | 1 | 2023 | 171 | 0.050 |
Why?
|
Child | 8 | 2022 | 80568 | 0.050 |
Why?
|
Accidental Falls | 1 | 2010 | 1079 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9527 | 0.050 |
Why?
|
History, 19th Century | 3 | 2011 | 711 | 0.050 |
Why?
|
Zambia | 1 | 2022 | 273 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2945 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 56 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 16039 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 1802 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2011 | 2076 | 0.050 |
Why?
|
Fluorescence | 1 | 2023 | 751 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 153 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 341 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2005 | 751 | 0.040 |
Why?
|
Pedigree | 2 | 2006 | 4535 | 0.040 |
Why?
|
Logistic Models | 3 | 2016 | 13273 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2011 | 1463 | 0.040 |
Why?
|
Brain Ischemia | 2 | 2013 | 3000 | 0.040 |
Why?
|
Biopsy | 2 | 2024 | 6766 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1539 | 0.040 |
Why?
|
Neurofibromin 1 | 1 | 2021 | 190 | 0.040 |
Why?
|
Insurance Coverage | 1 | 2011 | 1945 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4959 | 0.040 |
Why?
|
Child, Preschool | 6 | 2015 | 42510 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 226 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2513 | 0.040 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 97 | 0.040 |
Why?
|
Risk | 3 | 2016 | 9599 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 563 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2021 | 308 | 0.040 |
Why?
|
Reoperation | 2 | 2024 | 4308 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3530 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12768 | 0.040 |
Why?
|
Cell Lineage | 2 | 2019 | 2573 | 0.040 |
Why?
|
Social Environment | 1 | 2004 | 1010 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1739 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2010 | 2649 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6612 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 580 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6058 | 0.040 |
Why?
|
Risk Factors | 6 | 2019 | 74850 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2020 | 166 | 0.040 |
Why?
|
Tamoxifen | 1 | 2023 | 964 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 2 | 2023 | 2415 | 0.040 |
Why?
|
Medicare | 1 | 2016 | 6815 | 0.040 |
Why?
|
Age Factors | 2 | 2005 | 18382 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 702 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2013 | 3183 | 0.040 |
Why?
|
Animals | 11 | 2024 | 168735 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2014 | 10380 | 0.040 |
Why?
|
Contrast Media | 1 | 2011 | 5330 | 0.040 |
Why?
|
Informed Consent | 1 | 2024 | 1010 | 0.040 |
Why?
|
Time Factors | 6 | 2016 | 40097 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9525 | 0.040 |
Why?
|
Somatosensory Cortex | 1 | 2021 | 510 | 0.040 |
Why?
|
Health Resources | 1 | 2023 | 950 | 0.030 |
Why?
|
Radiography | 3 | 2014 | 6941 | 0.030 |
Why?
|
Cerebrovascular Circulation | 3 | 2012 | 2674 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22327 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 516 | 0.030 |
Why?
|
Vomiting | 1 | 2020 | 646 | 0.030 |
Why?
|
Phonetics | 1 | 2018 | 207 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2018 | 444 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.030 |
Why?
|
Acute Disease | 1 | 2007 | 7236 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2021 | 1253 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4278 | 0.030 |
Why?
|
Physics | 1 | 2016 | 92 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1343 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4617 | 0.030 |
Why?
|
Sphingosine | 1 | 2018 | 306 | 0.030 |
Why?
|
Internationality | 1 | 2022 | 1007 | 0.030 |
Why?
|
History, 20th Century | 3 | 2011 | 2760 | 0.030 |
Why?
|
Lysophospholipids | 1 | 2018 | 335 | 0.030 |
Why?
|
Lymphopenia | 1 | 2018 | 298 | 0.030 |
Why?
|
Tectum Mesencephali | 1 | 2015 | 18 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 735 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1117 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13446 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2023 | 1927 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 2015 | 59 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 6204 | 0.030 |
Why?
|
Audiometry | 1 | 2016 | 253 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2023 | 1192 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2019 | 11639 | 0.030 |
Why?
|
Sports | 1 | 2021 | 699 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2023 | 7842 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15401 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 152 | 0.030 |
Why?
|
Patient Admission | 2 | 2012 | 1365 | 0.030 |
Why?
|
Hospital Mortality | 3 | 2014 | 5339 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22340 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2341 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 510 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1553 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 245 | 0.030 |
Why?
|
Semantics | 1 | 2018 | 609 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 570 | 0.030 |
Why?
|
Wakefulness | 1 | 2021 | 1282 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1227 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 305 | 0.030 |
Why?
|
Endocytosis | 1 | 2018 | 952 | 0.030 |
Why?
|
Valine | 1 | 2015 | 410 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 947 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9239 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 322 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 189 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1162 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2081 | 0.030 |
Why?
|
Spinal Nerve Roots | 1 | 2013 | 122 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 384 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1239 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2016 | 414 | 0.030 |
Why?
|
Exosomes | 1 | 2017 | 417 | 0.030 |
Why?
|
Nicardipine | 1 | 2012 | 59 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 6544 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1926 | 0.030 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 340 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 636 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2015 | 636 | 0.020 |
Why?
|
Spleen | 1 | 2018 | 2294 | 0.020 |
Why?
|
Compassionate Use Trials | 1 | 2012 | 49 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4111 | 0.020 |
Why?
|
Glasgow Outcome Scale | 1 | 2012 | 101 | 0.020 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7871 | 0.020 |
Why?
|
Ear, Inner | 1 | 2016 | 426 | 0.020 |
Why?
|
Lumbosacral Region | 1 | 2013 | 295 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2000 | 1446 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3851 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3599 | 0.020 |
Why?
|
Deafness | 1 | 2016 | 461 | 0.020 |
Why?
|
Mice | 4 | 2021 | 81782 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2012 | 178 | 0.020 |
Why?
|
Anterior Cerebral Artery | 1 | 2011 | 49 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3202 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1389 | 0.020 |
Why?
|
Cochlear Implants | 1 | 2016 | 342 | 0.020 |
Why?
|
Point Mutation | 1 | 2016 | 1590 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 2013 | 323 | 0.020 |
Why?
|
Legislation, Medical | 1 | 2011 | 99 | 0.020 |
Why?
|
History, Medieval | 1 | 2011 | 62 | 0.020 |
Why?
|
History, 16th Century | 1 | 2011 | 69 | 0.020 |
Why?
|
Circle of Willis | 1 | 2011 | 76 | 0.020 |
Why?
|
History, 17th Century | 1 | 2011 | 108 | 0.020 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2011 | 59 | 0.020 |
Why?
|
Internal Fixators | 1 | 2011 | 183 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 963 | 0.020 |
Why?
|
Prevalence | 3 | 2012 | 15828 | 0.020 |
Why?
|
History, Ancient | 1 | 2011 | 213 | 0.020 |
Why?
|
Laminectomy | 1 | 2011 | 227 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1009 | 0.020 |
Why?
|
Vascular Malformations | 1 | 2016 | 470 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2012 | 479 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2012 | 616 | 0.020 |
Why?
|
Texas | 1 | 2011 | 410 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2012 | 329 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2011 | 268 | 0.020 |
Why?
|
Bicycling | 1 | 2011 | 176 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 816 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2120 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1181 | 0.020 |
Why?
|
Hip Joint | 1 | 2016 | 1000 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6838 | 0.020 |
Why?
|
Diskectomy | 1 | 2011 | 203 | 0.020 |
Why?
|
Hypertrophy | 1 | 2011 | 562 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1164 | 0.020 |
Why?
|
Thoracic Vertebrae | 1 | 2014 | 614 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2011 | 574 | 0.020 |
Why?
|
Iliac Artery | 1 | 2011 | 344 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 750 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 685 | 0.020 |
Why?
|
Radiculopathy | 1 | 2011 | 204 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 897 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 404 | 0.020 |
Why?
|
Losartan | 1 | 2011 | 263 | 0.020 |
Why?
|
Heart Block | 1 | 2011 | 391 | 0.020 |
Why?
|
Geography | 1 | 2011 | 651 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2837 | 0.020 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 994 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10086 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 913 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1504 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1369 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10727 | 0.020 |
Why?
|
Syncope | 1 | 2011 | 431 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1138 | 0.020 |
Why?
|
Knee Joint | 1 | 2016 | 1656 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2716 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2045 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 564 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4851 | 0.020 |
Why?
|
Movement Disorders | 1 | 2011 | 460 | 0.020 |
Why?
|
Decision Making | 1 | 2021 | 3955 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 13026 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 768 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2012 | 869 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1676 | 0.020 |
Why?
|
Orthopedic Procedures | 1 | 2016 | 1279 | 0.020 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1022 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2015 | 1678 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2611 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1885 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1605 | 0.020 |
Why?
|
Employment | 1 | 2012 | 1107 | 0.020 |
Why?
|
Cerebral Ventriculography | 1 | 2005 | 44 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2011 | 818 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1164 | 0.020 |
Why?
|
Arteries | 1 | 2011 | 1120 | 0.020 |
Why?
|
Drainage | 1 | 2011 | 1181 | 0.020 |
Why?
|
Trauma Centers | 1 | 2011 | 950 | 0.020 |
Why?
|
Symporters | 1 | 2008 | 362 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1721 | 0.020 |
Why?
|
Angiography | 1 | 2011 | 1589 | 0.020 |
Why?
|
Parietal Lobe | 1 | 2010 | 859 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14643 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2011 | 829 | 0.010 |
Why?
|
Regression Analysis | 1 | 2014 | 6321 | 0.010 |
Why?
|
History, 18th Century | 1 | 2005 | 206 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1447 | 0.010 |
Why?
|
Syndrome | 1 | 2011 | 3271 | 0.010 |
Why?
|
Benzamides | 1 | 2010 | 1376 | 0.010 |
Why?
|
Vision Disorders | 1 | 2011 | 1085 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9656 | 0.010 |
Why?
|
Cerebellum | 1 | 2011 | 1519 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2012 | 2188 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2040 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9334 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 1037 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6486 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5873 | 0.010 |
Why?
|
Motor Activity | 2 | 2004 | 2705 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3678 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5772 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11030 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7581 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4863 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4394 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2028 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8107 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10426 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3816 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18292 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2011 | 3094 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5880 | 0.010 |
Why?
|
Piperazines | 1 | 2010 | 2546 | 0.010 |
Why?
|
Aspirin | 1 | 2011 | 3135 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2011 | 2769 | 0.010 |
Why?
|
Maze Learning | 1 | 2000 | 482 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8882 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18962 | 0.010 |
Why?
|
Patient Discharge | 1 | 2011 | 3460 | 0.010 |
Why?
|
Pyrimidines | 1 | 2010 | 3049 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3796 | 0.010 |
Why?
|
Thrombosis | 1 | 2011 | 2955 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5364 | 0.010 |
Why?
|
Comorbidity | 1 | 2011 | 10575 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2004 | 1866 | 0.010 |
Why?
|
Rats | 2 | 2004 | 23708 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6542 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14745 | 0.010 |
Why?
|
Smoking | 1 | 2011 | 9082 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12129 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24275 | 0.010 |
Why?
|
Environment | 1 | 2000 | 1119 | 0.010 |
Why?
|
Recovery of Function | 1 | 2004 | 2963 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10810 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26380 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 30230 | 0.010 |
Why?
|
Phenotype | 1 | 2006 | 16714 | 0.000 |
Why?
|
Cognition | 1 | 2000 | 7043 | 0.000 |
Why?
|